See also this year's filing and all EDGAR filings for this company.
PDF Report 0001815974_2023_Anebulo_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001815974, Anebulo Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 0 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 15,579,431 |
| 4 | LiabilitiesCurrent | 380,828 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 131,703 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,869,636 |
| 9 | ResearchAndDevelopmentExpense | 2,961,538 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 5,555 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 15,579,431 |
| 1 | Liabilities | 512,531 |
| 2 | Expenses | 6,831,174 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 15,066,900 |
| 5 | NetIncome | -6,825,619 |
| 6 | ComprehensiveNetIncome | -6,825,619 |
| 7 | BaseVar | 11,464,346 |
| 8 | EconomicCapitalRatio | 2.37 |
Edgar->Model Mapping
Feature Distribution
Change over Time
